RTW INVESTMENTS, LP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$362,422,448
+3.1%
17,687,7720.0%7.65%
+14.3%
Q2 2023$351,456,030
+16.0%
17,687,7720.0%6.69%
+6.1%
Q1 2023$302,991,534
-12.5%
17,687,7720.0%6.31%
-10.7%
Q4 2022$346,149,698
+37.2%
17,687,772
+11.9%
7.07%
+21.5%
Q3 2022$252,213,000
+16.0%
15,802,8020.0%5.82%
+3.5%
Q2 2022$217,447,000
-13.2%
15,802,8020.0%5.62%
+8.3%
Q1 2022$250,632,000
-27.3%
15,802,8020.0%5.19%
+3.0%
Q4 2021$344,975,000
-26.5%
15,802,8020.0%5.04%
-28.9%
Q3 2021$469,601,000
-29.3%
15,802,802
+5.4%
7.08%
-29.3%
Q2 2021$663,920,000
-4.8%
14,990,286
-4.6%
10.02%
-8.0%
Q1 2021$697,287,000
-25.5%
15,715,286
-7.9%
10.88%
-30.7%
Q4 2020$935,582,000
+143.4%
17,060,211
+1.5%
15.70%
+69.6%
Q3 2020$384,334,000
+9.2%
16,812,4910.0%9.25%
-6.5%
Q2 2020$351,885,000
+50.0%
16,812,4910.0%9.90%
-1.9%
Q1 2020$234,534,000
-38.7%
16,812,4910.0%10.10%
-30.1%
Q4 2019$382,652,000
+98.8%
16,812,491
+1.4%
14.44%
+26.1%
Q3 2019$192,503,000
-22.6%
16,587,4910.0%11.45%
-13.9%
Q2 2019$248,812,000
-11.2%
16,587,491
+3.4%
13.29%
-30.5%
Q1 2019$280,250,000
+18.8%
16,037,4860.0%19.13%
-12.9%
Q4 2018$235,848,000
-36.0%
16,037,486
+7.1%
21.95%
-0.5%
Q3 2018$368,555,000
+27.3%
14,969,7440.0%22.07%
+5.7%
Q2 2018$289,448,000
+12.1%
14,969,7440.0%20.88%
-15.1%
Q1 2018$258,228,00014,969,74424.58%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders